EBIT: Income before interest and taxes.
Tectonic Therapeutic, Inc. (TECX) had EBIT of $-84.04M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-74.15M |
|
-- |
|
-- |
|
$84.04M |
|
$-84.04M |
|
$11.12M |
|
$-72.92M |
|
$-72.92M |
|
$-74.15M |
|
$-74.15M |
|
$-74.15M |
|
$-74.15M |
|
|
EBIT |
$-84.04M |
$-82.66M |
|
18.32M |
|
18.32M |
|
$-4.05 |
|
$-4.05 |
|
| Balance Sheet Financials | |
$257.36M |
|
$1.19M |
|
$3.68M |
|
$261.04M |
|
$9.67M |
|
$0.04M |
|
$0.04M |
|
$9.71M |
|
$251.33M |
|
$251.33M |
|
$251.33M |
|
18.74M |
|
| Cash Flow Statement Financials | |
$-60.08M |
|
$-0.14M |
|
$173.35M |
|
$141.83M |
|
$254.87M |
|
$113.04M |
|
$10.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
26.63 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-60.22M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-29.50% |
|
-29.50% |
|
-28.41% |
|
-29.50% |
|
$13.41 |
|
$-3.29 |
|
$-3.28 |
|